Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

被引：0

作者：

Xiang-Ping Yang

Kamran Ghoreschi

Scott M Steward-Tharp

Jaime Rodriguez-Canales

Jinfang Zhu

John R Grainger

Kiyoshi Hirahara

Hong-Wei Sun

Lai Wei

Golnaz Vahedi

Yuka Kanno

John J O'Shea

Arian Laurence

机构：

[1] Molecular Immunology and Inflammation Branch,

[2] National Institute of Arthritis,undefined

[3] Musculoskeletal and Skin Diseases,undefined

[4] National Institutes of Health,undefined

[5] Laser Capture Microdissection Core Laboratory of Pathology,undefined

[6] National Cancer Institute,undefined

[7] National Institutes of Health,undefined

[8] Laboratory of Immunology,undefined

[9] National Institute of Allergy and Infectious Diseases,undefined

[10] National Institutes of Health,undefined

[11] Mucosal Immunology Section,undefined

[12] National Institute of Allergy and Infectious Diseases,undefined

[13] National Institutes of Health,undefined

[14] Clinical Immunology Section,undefined

[15] National Eye Institute,undefined

[16] National Institutes of Health,undefined

来源：

Nature Immunology | 2011年 / 12卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Loss of IL-2 signaling results in autoimmunity. Laurence and colleagues show that the IL-2–STAT5 axis counteracts STAT3 activation of Il17 to dampen IL-17 production independently of Foxp3.

引用

页码：247 / 254

页数：7

共 50 条

[21] Upregulated expression of STAT3/IL-17 in patients with systemic lupus erythematosus
Chen, Shih-Yao
Liu, Ming-Fei
Kuo, Pin-Yu
Wang, Chrong-Reen
CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1361 - 1366
[22] Simultaneous detection of STAT1, STAT3, and STAT5 activation in response to interferons
Brodey, Mary M.
Zheng, Wei
Wang, Jimin
Reagan, Kevin
CYTOKINE, 2008, 43 (03) : 241 - 241
[23] Stat3 and Stat4 direct development of IL-17-secreting Th cells
Mathur, Anubhav N.
Chang, Hua-Chen
Zisoulis, Dimitrios G.
Stritesky, Gretta L.
Yu, Qing
O'Malley, John T.
Kapur, Reuben
Levy, David E.
Kansas, Geoffrey S.
Kaplan, Mark H.
JOURNAL OF IMMUNOLOGY, 2007, 178 (08): : 4901 - 4907
[24] STAT3 and STAT5 Targeting for Simultaneous Management of Melanoma and Autoimmune Diseases
Logotheti, Stella
Puetzer, Brigitte M.
CANCERS, 2019, 11 (10)
[25] THROMBOPOIETIN (TPO) INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT5 AND STAT3
BACON, CM
TORTOLANI, PJ
SHIMOSAKA, A
REES, RC
LONGO, DL
OSHEA, JJ
FEBS LETTERS, 1995, 370 (1-2) : 63 - 68
[26] Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
Brachet-Botineau, Marie
Polomski, Marion
Neubauer, Heidi A.
Juen, Ludovic
Hedou, Damien
Viaud-Massuard, Marie-Claude
Prie, Gildas
Gouilleux, Fabrice
CANCERS, 2020, 12 (01)
[27] IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
Camporeale, Annalisa
Poli, Valeria
FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 : 2306 - 2326
[28] STAT3,STAT5靶向肿瘤治疗研究进展
曹兵
王鸿程
国际内科学杂志, 2007, (09) : 518 - 520
[29] STAT3 and STAT5 regulations in gallic Acid & quercetin treated cells
Gul, Huseyin
Zergeroglu, Asuman Demiroglu
ANTI-CANCER DRUGS, 2015, 26 : E27 - E27
[30] The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
Shi, Aiping
Dong, Jie
Hilsenbeck, Susan
Bi, Lirong
Zhang, Hong
Li, Yi
PLOS ONE, 2015, 10 (07):

← 1 2 3 4 5 →